ISIN | Jotup

Name Change to Ultra Lithium Inc.

Retrieved on:

Wednesday, January 19, 2022 - 7:53pm

Lithium, ISIN, Gold, GLOBE, Company, CUSIP, Board, Acquisition

VANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Ultra Resources Inc. (TSX-V: ULT) (Ultra Resources or the Company) announces that the Board of Directors of the Company has resolved to change the name of the Company from Ultra Resources Inc. to Ultra Lithium Inc.

Key Points:

VANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Ultra Resources Inc. (TSX-V: ULT) (Ultra Resources or the Company) announces that the Board of Directors of the Company has resolved to change the name of the Company from Ultra Resources Inc. to Ultra Lithium Inc.
The Companys trading symbol ULT will remain unchanged and the Company will resume trading under its new name Ultra Lithium Inc. on January 21, 2022.
Ultra Resources Inc. is an exploration and development company with a focus on the acquisition and development of lithium, gold, and copper assets.
The Company holds a brine lithium property in Argentina, and hard rock spodumene type lithium properties at Georgia Lake / Forgan Lake area in northwestern Ontario, Canada, and a brine lithium property in the Big Smoky Valley, Nevada, USA.

DGAP-News: wallstreet:online doubles securities accounts and assets under custody in 2021 - Smartbroker grows by 140% to 200,000 accounts

Retrieved on:

Wednesday, January 19, 2022 - 8:26pm

FSE, Federal, Wall, Group, AUC Libraries and Learning Technologies, Federal Financial Supervisory Authority, ISIN, Growth, CEO, AG, Review, Time, Neo, Company, Mission statement, Financial adviser, Financial services, Bank

The Group was able to more than double the number of securities accounts as well as assets under custody during the past year.

Key Points:

The Group was able to more than double the number of securities accounts as well as assets under custody during the past year.
As of 31 December 2021, the subsidiary wallstreet:online capital AG managed around 240,000 securities accounts, of which 200,000 through Smartbroker, the Group's multiple full-service neo broker.
wallstreet:online capital AG is by now the largest neo broker operator in Germany measured by assets under custody.
Savings plans are likewise very popular: the number of active savings plans increased by 170% to 105,000 at the end of 2021.

DGAP-News: DIC Asset AG: 2022 off to an excellent start - with around 40,000 sqm of office space in Frankfurt let to Deutsche Bank

Retrieved on:

Wednesday, January 19, 2022 - 8:26pm

Leadership in Energy and Environmental Design, ISIN, Workplace, CEO, IBC, EV, Frankfurt, Deutsche Bank, SDAX, Biodiversity, DIC, LEED, Online gambling, Real estate, New Work, Campus

DIC Asset AG ("DIC"), ISIN: DE000A1X3XX4, one of Germany's leading listed property companies, started 2022 off with a successful large-scale letting transaction.

Key Points:

DIC Asset AG ("DIC"), ISIN: DE000A1X3XX4, one of Germany's leading listed property companies, started 2022 off with a successful large-scale letting transaction.
DIC renewed the bank's unexpired lease agreement for about 32,000 sqm at the IBC office scheme in Frankfurt early on while letting an additional unit of 7,700 sqm to the bank.
The lease term for a total of 39,700 sqm of state-of-the-art office space in the office tower approximates ten years.
What is so special about it: Deutsche Bank has requested an office structure fit for tomorrow's New Work format.

DGAP-News: Evotec and Lilly enter into drug discovery collaboration in metabolic diseases

Retrieved on:

Wednesday, January 19, 2022 - 8:26pm

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company ("Lilly") in the field of metabolic diseases with a focus on kidney diseases and diabetes.

Key Points:

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company ("Lilly") in the field of metabolic diseases with a focus on kidney diseases and diabetes.
Evotec will be responsible for the discovery of potential drug candidates for the treatment of diabetes and chronic kidney diseases from targets identified by Lilly or by Evotec.
Dr Cord Dohrmann, Chief Scientific Officer of Evotec, commented: "We are excited to enter into this research partnership with Lilly.
Evotec's patient-derived molecular data in combination with our omics-supported multimodality drug discovery platform delivers highest quality drug candidates for our partners.

EQS-News: Achiko AG Announces Feature Article on How We Get Back to Normal with its AptameXTM Covid-19 Rapid Test Technology

Retrieved on:

Wednesday, January 19, 2022 - 8:25pm

The Jakarta Post, PCR, CE marking, ISIN, ACHI, News, TM, COVID-19, Confidence, Medical device

The article is available at this link: https://www.thejakartapost.com/adv-longform/2022/01/17/how-we-get-back-t... and within the News section of Achiko's web site: https://www.achiko.com/news .

Key Points:

The article is available at this link: https://www.thejakartapost.com/adv-longform/2022/01/17/how-we-get-back-t... and within the News section of Achiko's web site: https://www.achiko.com/news .
Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com ) is developing disruptive diagnostic solutions that puts people first.
The company's lead product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport.
Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameXTM and companion health apps via its digital mobile health technology division, Teman SehatTM.

DGAP-News: ACCENTRO Achieves New Record Level in Housing Sales

Retrieved on:

Wednesday, January 19, 2022 - 8:24pm

City, Sale, Frankfurt Stock Exchange, Housing, ISIN, EUR, CEO, Real estate, WKN

Berlin, 18 January 2022 - ACCENTRO Real Estate AG, a residential real estate investor and Germany's leading housing privatisation company, looks back on a very successful year 2021 in its housing privatisation business.

Key Points:

Berlin, 18 January 2022 - ACCENTRO Real Estate AG, a residential real estate investor and Germany's leading housing privatisation company, looks back on a very successful year 2021 in its housing privatisation business.
The notarised volume of condominium sales reached a new record level: Climbing by 107.7 % to EUR 246.5 million (previous year: EUR 118.7 million), it more than doubled in 2021.
Lars Schriewer, CEO of ACCENTRO Real Estate AG, is very satisfied: "The German housing market again developed very dynamically last year.
Our strong sales pipeline continues to be well-filled, amounting to around EUR 360 million sales volume in the housing privatisation business alone.

DGAP-News: Disclosure of share buy-backs in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052: 1st Interim Report

Retrieved on:

Wednesday, January 19, 2022 - 8:23pm

Kepler, XETRA, HelloFresh, Disclosure, ISIN, Article, Interim, EUR, Program, Company, Medical device, EU

Disclosure of share buy-backs in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052: 1st Interim Report

Key Points:

Disclosure of share buy-backs in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052: 1st Interim Report
The issuer is solely responsible for the content of this announcement.
Under the first tranche, the Company may acquire shares for up to EUR 125 million in the period from 11 January 2022 to (and including) 31 March 2022.
The Company announced the terms of this program on the same date in accordance with Article 5(1)(a) of Regulation (EU) No 596/2014 and Article 2(1) of Commission Delegated Regulation (EU) 2016/1052.
In the period from 11 January 2022 to (and including) 14 January 2022, shares were repurchased under the program by Kepler Cheuvreux on Xetra as follows:

DGAP-News: UET United Electronic Technology AG strengthens Management for upcoming development

Retrieved on:

Wednesday, January 19, 2022 - 8:23pm

DZ Bank, ISIN, Swedish, Solution, COVID, Management, Bank, Financial technology

UET United Electronic Technology AG (ISIN: DE000A0LBKW6), Eschborn, announces that Antje Lobisch will strengthen the existing management of the UET Group as new CFO (Chief Financial Officer).

Key Points:

UET United Electronic Technology AG (ISIN: DE000A0LBKW6), Eschborn, announces that Antje Lobisch will strengthen the existing management of the UET Group as new CFO (Chief Financial Officer).
After further positions in Fintech's and the automotive supplier Vibracoustic with responsibility for treasury and investment management, Antje Lobisch is now responsible for the development of the entire financial area of the UET Group and all group companies.
With this development we have to focus more on the further development of our financial position.
With broad experience, dynamism and understanding of technology-driven international business development, Antje Lobisch strengthens our team perfectly, and exactly at the right time," says chairman of the board Werner Neubauer.

DGAP-News: Abivax's phase 1/2 clinical study results of ABX196 in liver cancer to be presented on Jan. 21, at ASCO GI Cancers Symposium 2022

Retrieved on:

Wednesday, January 19, 2022 - 8:23pm

Abivax's phase 1/2 clinical study results of ABX196 in liver cancer to be presented on Jan. 21, at ASCO GI Cancers Symposium 2022

Key Points:

Abivax's phase 1/2 clinical study results of ABX196 in liver cancer to be presented on Jan. 21, at ASCO GI Cancers Symposium 2022
The issuer is solely responsible for the content of this announcement.
The ASCO GI Cancers Symposium is one of the most important international conferences to present and discuss the latest, most innovative and promising research advances in the field of gastrointestinal cancer.
It is organized every year by the American Society of Clinical Oncology (ASCO), the world's leading organization in cancer research.
The selection of our clinical data for a presentation at ASCO GI Cancers Symposium confirms the potential benefit of our second clinical compound for liver cancer patients who were previously failing on checkpoint inhibitor treatments.

DGAP-News: DEMIRE Deutsche Mittelstand Real Estate AG: momox continues to grow at LogPark Leipzig

Retrieved on:

Wednesday, January 19, 2022 - 8:23pm

DEMIRE Deutsche Mittelstand Real Estate AG: momox continues to grow at LogPark Leipzig

Key Points:

DEMIRE Deutsche Mittelstand Real Estate AG: momox continues to grow at LogPark Leipzig
The issuer is solely responsible for the content of this announcement.
DEMIRE Deutsche Mittelstand Real Estate AG (ISIN: DE000A0XFSF0) has strengthened its relationship with LogPark Leipzig's largest tenant, the re-commerce company momox, and given it a long-term orientation.
Ingo Hartlief, CEO of DEMIRE AG, adds: "We are very pleased that momox continues to prosper, grow and commit to LogPark in the long term.
DEMIRE Deutsche Mittelstand Real Estate AG acquires and holds commercial real estate in mid-sized cities and up-and-coming locations bordering metropolitan areas across German.